100 related articles for article (PubMed ID: 8120565)
1. Liposomal-doxorubicin in human immunodeficiency virus-associated Kaposi's sarcoma.
Poizot-Martin I; Giovannini M; Rosello R; Viallat JR; Sauniere JF; Dalmas AM; Genre D; Dhiver C; Gastaut JA
J Clin Oncol; 1994 Mar; 12(3):645. PubMed ID: 8120565
[No Abstract] [Full Text] [Related]
2. Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin.
Gottlieb JJ; Washenik K; Chachoua A; Friedman-Kien A
Lancet; 1997 Nov; 350(9088):1363-4. PubMed ID: 9365453
[No Abstract] [Full Text] [Related]
3. Treatment of Kaposi's sarcoma with liposomal doxorubicin.
Bergin C; O'Leary A; McCreary C; Sabra K; Mulcahy F
Am J Health Syst Pharm; 1995 Sep; 52(18):2001-4. PubMed ID: 8528867
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma.
Hjortsberg C; Persson U; Lidbrink E; Bennett C
Acta Oncol; 1999; 38(8):1063-7. PubMed ID: 10665764
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma.
Amantea MA; Forrest A; Northfelt DW; Mamelok R
Clin Pharmacol Ther; 1997 Mar; 61(3):301-11. PubMed ID: 9084455
[TBL] [Abstract][Full Text] [Related]
6. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ
J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358
[TBL] [Abstract][Full Text] [Related]
8. Liposomal drug targeting in the treatment of Kaposi's sarcoma.
Wernz JC
AIDS Patient Care STDS; 1996 Dec; 10(6):362-7. PubMed ID: 11361553
[No Abstract] [Full Text] [Related]
9. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
Simpson JK; Miller RF; Spittle MF
Clin Oncol (R Coll Radiol); 1993; 5(6):372-4. PubMed ID: 8305358
[TBL] [Abstract][Full Text] [Related]
10. Liposomal doxorubicin in pulmonary Kaposi's sarcoma: improved survival as compared to patients without liposomal doxorubicin.
Grünaug M; Bogner JR; Loch O; Goebel FD
Eur J Med Res; 1998 Feb; 3(1-2):13-9. PubMed ID: 9512962
[TBL] [Abstract][Full Text] [Related]
11. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery.
Lichterfeld M; Qurishi N; Hoffmann C; Hochdorfer B; Brockmeyer NH; Arasteh K; Mauss S; Rockstroh JK;
Infection; 2005 Jun; 33(3):140-7. PubMed ID: 15940415
[TBL] [Abstract][Full Text] [Related]
12. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma: long-term experiences.
Wagner D; Kern WV; Kern P
Clin Investig; 1994 Jun; 72(6):417-23. PubMed ID: 7950152
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma after renal transplantation: treatment with liposomal doxorubicin.
Boehringer M; Schwarz A; Keller F
Nephrol Dial Transplant; 1999 May; 14(5):1342-3. PubMed ID: 10344407
[No Abstract] [Full Text] [Related]
14. Liposomal KS drugs approved.
GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
[TBL] [Abstract][Full Text] [Related]
15. Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma.
White RM
AIDS; 1997 Sep; 11(11):1412-3. PubMed ID: 9302461
[No Abstract] [Full Text] [Related]
16. Kaposi's sarcoma: DaunoXome approved.
AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485
[TBL] [Abstract][Full Text] [Related]
17. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
[TBL] [Abstract][Full Text] [Related]
18. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
Kreuter A; Gambichler T; Schlottmann R; Altmeyer P; Brockmeyer N
Acta Derm Venereol; 2001; 81(3):224. PubMed ID: 11558892
[No Abstract] [Full Text] [Related]
19. Liposomal chemotherapies.
Smart T
GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
[TBL] [Abstract][Full Text] [Related]
20. Liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
Hengge UR; Brockmeyer NH; Baumann M; Reimann G; Goos M
Lancet; 1993 Aug; 342(8869):497. PubMed ID: 8102452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
